CJCR Annual Report (2015)

In 2015, CJCR has a significant increase of citations. The impact factor of 2014 is 1.935. Apart from the regular issues, CJCR published three focused issues/series on cancer statistics: updated cancer burden in China, circulating tumor cells and pancreatic cancer. Dr. Qimin Zhan and Dr. Lin Kong are warmly welcome to our editorial board. More information is shown below in the Annual Report.

Thank you so much for all your efforts and look forward to working closely with you in 2016.

Read More>>

2014 Impact Factor of CJCR: 1.935

In the recent three years, CJCR has been making tremendous progresses in a steady way. Its IF has grown from 0.182 (2011), to 0.448 (2012), to 0.932 (2013) and now 1.935 (2014) (Figure 1). The journal developed from a quarterly publication to a bi-monthly journal in 2013 ever since it was transferred to AME Publishing Company to be in charge of its publication. Journal of Thoracic Disease, another journal published by AME Publishing Company, also makes its debut of receiving the first IF: 1.783.

Read More>>

Testimonials from Prominent Physician Investigator

Prominent physician investigators, including editorial board members, authors, and readers, who know the journal well, provided testimonials for CJCR. We are thankful for their support for the journal.

Read More>>

CJCR will exhibit in the American College of Surgeons (ACS) Clinical Congress 2015 in Chicago

The American College of Surgeons (ACS) Clinical Congress 2015 is to be held at the McCormick Place, Chicago, IL, USA from October 4th to October 8th. As an international, open access, peer-review journal, Chinese Journal of Cancer Research (CJCR) will take this opportunity to exhibit the journal and meet our editorial board members, reviewers, authors and readers. Our booth “AME Publishing Company” stands at No.1140 in the exhibition hall.

Read More>>

Annual report on status of cancer in China, 2011

Map of the 177 contributing cancer registries and geographic regions in China (the dots are location of the cancer registries).

Read More>>

Transcatheter embolization therapy in liver cancer: an update of clinical evidences

Principle of conventional transarterial chemoembolization. Reproduced with the permission from ref.

Read More>>

The status, limitation and improvement of adoptive cellular immunotherapy in advanced urologic malignancies

Mutiple immunologic mechanisms contribute to deplete or inhibit suppressive immunocytes, such as Treg, MDSC and TAM, in vivo in patients with cancer. MDSC, myeloid-derived suppressor cell; TAM, tumor-associated macrophage.

Read More>>

Activation of Toll-like receptors signaling in non-small cell lung cancer cell line induced by tumor-associated macrophages

THP-1 cell line differentiated into M2-type macrophages. (A) Expressions of CD68 and CD206 in M2-type macrophages by flow cytometry. M2-type macrophage phenotypes CD68 and CD206 were highly expressed in M2-type macrophages; (B) Expression of CD206 in M2-type macrophages by direct immunofluorescence assay……

Read More>>

Prediction of radiosensitivity in primary central nervous system germ cell tumors using dynamic contrast-enhanced magnetic resonance imaging

MR images in an 11-year-old female patient with pineal region mass sensitive to RT. The mass shows marked hyperintensities in Ktrans map (A) and Ve map (B); and marked hypointensities in Kep map (C). Enhanced T1-weighted MRI (D) demonstrates that the mass has obvious homogeneous enhancement. RT, radiation therapy; MRI, magnetic resonance imaging.

Read More>>

microRNA-218 suppresses the proliferation, invasion and promotes apoptosis of pancreatic cancer cells by targeting HMGB1

The effects of miR-218 on the proliferation of PANC-1 cells (flow cytometry). **P<0.01 vs. normal ctrl group or mimic ctrl group.

Read More>>

Preclinical characterization and validation of a dual-labeled trastuzumab-based imaging agent for diagnosing breast cancer

Internalization of [¹¹¹In]-DTPA-trastuzumab-IRDye 800 into SKBR-3 cells incubated for 4 and 24 h at 37 °C. (A) SKBR-3 cells in wells were scanned with a LI-COR Odyssey near-infrared imaging system; (B) fluorescence intensity surface plot of SKBR-3 cells with radioconjugate uptake at 4 and 24 h.

Read More>>